Updated Jul 16, 2026
Burkly Linda has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $18K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | EDIT | Editas Medicine, Inc. | S — Open-market sale | 731 | $2.70 | $2K |
| 2026-03-04 | EDIT | Editas Medicine, Inc. | S — Open-market sale | 749 | $2.02 | $2K |
| 2025-09-03 | EDIT | Editas Medicine, Inc. | S — Open-market sale | 710 | $2.60 | $2K |
| 2025-07-31 | EDIT | Editas Medicine, Inc. | S — Open-market sale | 5.1K | $2.49 | $13K |
Burkly Linda is a corporate insider — currently tracked as EVP, CHIEF SCIENTIFIC OFFICER of Editas Medicine, Inc. (EDIT). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($18K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Burkly Linda profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.